--- url: 'https://qubit.capital/blog/europe-series-b-plus-weekly-funding-roundup-week-5-june-2026' title: 'Europe Series B+ Weekly Funding Roundup (Jun 22-29, 2026): $630.0M Raised Across 2 Deals' author: name: Mayur Toshniwal url: 'https://qubit.capital/blog/author/mayur' date: '2026-06-29T12:02:43+05:30' modified: '2026-06-29T12:02:43+05:30' type: post summary: 'Europe''s late-stage funding week: Alan raised $520M for prevention-first health insurance and Taktile raised $110M for AI decisioning in finance.' categories: - Weekly Funding Roundup image: 'https://qubit.capital/wp-content/uploads/2026/06/featured-europe-series-bplus-67945.webp' published: true --- # Europe Series B+ Weekly Funding Roundup (Jun 22-29, 2026): $630.0M Raised Across 2 Deals Europe’s late-stage funding week came down to two companies and $630.0M. Alan, the French health insurer, took the bulk of it with a $520M round at a €5.5B valuation. Taktile, the Berlin decisioning platform, raised $110M led by Goldman Sachs Alternatives. Both are healthtech and fintech names that have been building for years, not overnight stories. The thread connecting them is AI sitting inside a regulated product rather than bolted onto it. Alan runs a physician-supervised assistant across its insurance and care platform. Taktile sells an auditable AI layer that banks and insurers can actually deploy. In both cases the pitch is the same: automate the hard parts, keep a human accountable, and make the controls something a regulator can inspect. Weekly Funding Roundup JUN 22-29, 2026 $630M TOTAL RAISED 2DEALS CLOSED MixedSTAGE $315MAVG DEAL SIZE EUROPETOP REGION BY STAGE Series G (late-stage / Series B+)$520M83% Series C (Series B+)$110M17% BY SECTOR AlanHealthtech, digital health insurance$520M TaktileFintech, risk and decisioning infrastructure$110M Table of Contents - [1. Alan Raises $520M For Prevention-First Health Insurance](#1-alan-raises-$520m-for-prevention-first-health-insurance) [Deal Overview](#deal-overview) - [Investor Profile](#investor-profile) - [Company and Leadership](#company-and-leadership) - [Problem and Opportunity](#problem-and-opportunity) - [Product and Technology](#product-and-technology) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision) - [Market Context](#market-context) - [2. Taktile Raises $110M For AI Decisioning In Finance](#2-taktile-raises-$110m-for-ai-decisioning-in-finance) [Deal Overview](#deal-overview-1) - [Investor Profile](#investor-profile-1) - [Company and Leadership](#company-and-leadership-1) - [Problem and Opportunity](#problem-and-opportunity-1) - [Product and Technology](#product-and-technology-1) - [Use of Proceeds and Vision](#use-of-proceeds-and-vision-1) - [Market Context](#market-context-1) - [Lessons For Founders](#lessons-for-founders) ## 1. Alan Raises $520M For Prevention-First Health Insurance ### Deal Overview - **Stage:** Series G (late-stage / Series B+) - **Sector:** Healthtech, digital health insurance - **Geography:** Paris, France - **Round size:** €480M (about $520M), mixing primary and secondary equity - **Valuation:** €5.5B, up from €5B in March 2026 ### Investor Profile [Alan](https://alan.com) raised the round with Prosus as lead, joined by Index Ventures, Teachers’ Venture Growth, and new backer Dara Holdings. Index has now backed Alan repeatedly, including the €100M round earlier in 2026. Prosus is the strategic piece. Its release cites roughly €400M (~$460M) for its own portion against the €480M total widely reported. The plan is to help Alan scale its consumer offering, enter markets where Prosus already operates, and tap its commerce models. That makes this more than a check. ### Company and Leadership Alan was founded in 2016 by CEO Jean-Charles Samuelian-Werve and CTO Charles Gorintin. It became the first newly licensed independent health insurer in France since the 1980s. Gorintin previously led data science at Facebook, Instagram, and Twitter, which shows up in how the company treats member data. The team has raised across nine-plus rounds since the 2016 seed. ### Problem and Opportunity Most insurers make money by optimizing margins on claims. Alan’s argument is that the model itself is broken when it waits for people to get sick. Samuelian-Werve frames it bluntly: health can’t wait for symptoms to worsen or for a six-month appointment. That gap, the distance between paying for care and actually keeping members healthy, is what Alan is trying to own. ### Product and Technology Alan is a licensed insurance carrier and a digital care platform in one. It serves over 1.1M members across France, Belgium, Spain, and Canada with around 850 employees, a thin headcount for that scale. The platform automates reimbursements (70% within an hour, 99% within 24 hours), runs 7-day telemedicine, and offers mental-health and therapy services. Its AI assistant, Mo, runs OpenAI, Anthropic, and Mistral models, but a doctor reviews every message within 15 minutes. Owning both the payer and the provider side gives Alan continuous health data that resellers can’t match. ### Use of Proceeds and Vision The money funds four things: new countries, deeper presence in its four current markets, acquisitions, and more spending on AI and healthcare services. Alan calls its category “prevention insurance” and pitches itself as a health partner, not a carrier. Gorintin’s longer view is a system that within 20 years cultivates good health rather than just treating disease. ### Market Context Alan is one of Europe’s most valuable healthtech companies, with more than €800M ARR growing 53% year over year and profitability in France. Its closest US comparison is Oscar Health, though Oscar’s losses make that imperfect. The real day-to-day rivals are French mutuelles and insurers like Groupe Vyv, Malakoff Humanis, and Axa France. They dwarf Alan on members but trail it on digital experience. ## 2. Taktile Raises $110M For AI Decisioning In Finance ### Deal Overview - **Stage:** Series C (Series B+) - **Sector:** Fintech, risk and decisioning infrastructure - **Geography:** Berlin, Germany - **Round size:** $110M, bringing total funding to about $184M - **Customers:** Allianz, Monzo, Mercury, ABN AMRO, Pleo, and others ### Investor Profile [Taktile](https://taktile.com) raised the round from Growth Equity at Goldman Sachs Alternatives, with Index Ventures, Tiger Global, Y Combinator, Dig Ventures, and Balderton Capital, which led the prior Series B. Having a major bank’s growth arm lead matters here. Taktile sells to regulated financial institutions, and that kind of lead investor reads as a credibility signal to the buyers it’s chasing. ### Company and Leadership Taktile was founded in 2020 by Maik Taro Wehmeyer and Maximilian Eber, former QuantCo leaders who met at Harvard. The company runs engineering out of Berlin with offices in New York and London, and it sells across the US and Europe. The round follows a roughly $4.7M seed in 2021, a $20M Series A in 2022, and a $54M Series B in February 2025. ### Problem and Opportunity Banks and insurers want to automate underwriting, identity checks, fraud, and AML. The blocker isn’t ambition, it’s the black-box problem. Regulators won’t accept a decision an institution can’t explain. Taktile’s answer is to make the reasoning visible. Every AI output exposes its full chain of logic, with validation at each step. ### Product and Technology Taktile is a no-code platform that lets finance and insurance teams build decision flows and AI agents that pair machine speed with human oversight. The pieces include an AI Agent Manager, a Decision Engine, a Case Manager, and a unified data layer. It integrates with more than 25 data and model providers, including Experian, Equifax, Plaid, Snowflake, OpenAI, and Anthropic. Reported results include 95% automation in B2B underwriting and 75% fewer AML false positives. The moat is less about raw data and more about being the embedded, auditable decisioning layer institutions trust. ### Use of Proceeds and Vision The $110M goes toward stronger AI for complex banking and insurance work and a wider footprint across the US, EMEA, and LATAM. Taktile wants to be the platform behind what it calls the agentic financial institution. The framing is consistent: AI is ready for finance when it comes with transparency and a human in the loop. ### Market Context Taktile sits in the risk-decisioning and AI-for-finance market, where auditability gates adoption. Competitors include Provenir, Alloy, and Oscilar, plus incumbent rules engines and a wave of agentic-AI entrants. Demand is driven by pressure to cut manual review costs, which Taktile pegs at 98%-plus faster decisions, and by rules that reward transparent AI over opaque models. ## Lessons For Founders - Vertical integration pays in regulated markets. Alan owns both the payer and the provider side, which is why it serves 1.1M members with about 850 people. That cost structure is hard for legacy insurers to copy. - A strategic lead beats a bigger check. Prosus brings market access and AI assets; Goldman Sachs Alternatives brings credibility with the exact buyers Taktile sells to. Pick investors who shorten your path, not just your runway. - In high-stakes AI, transparency is the product. Both companies keep a human accountable and make their systems inspectable. That’s what unlocks deployment in healthcare and finance. - Profitability buys leverage. Alan is profitable in France with €800M-plus ARR, which let it raise at a higher valuation on its own terms. Strong unit economics change the conversation with investors. - Years of groundwork show up as fast rounds. Neither company is new. Taktile has built since 2020, Alan since 2016. Late-stage capital flows to teams with a track record, not just a pitch.